Cargando…
Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma
BACKGROUND: Multiple myeloma (MM) is a clonal B cell malignancy characterized by proliferation of malignant plasma cells in the bone marrow. Despite high-dose melphalan therapy with autologous stem cell transplantation (ASCT) and the introduction of immunomodulatory drugs like bortezomib or lenalido...
Autores principales: | Koerber, Ruth-Miriam, Held, Stefanie Andrea Erika, Heine, Annkristin, Kotthoff, Philipp, Daecke, Solveig Nora, Bringmann, Anita, Brossart, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526421/ https://www.ncbi.nlm.nih.gov/pubmed/26251761 http://dx.doi.org/10.1186/s40164-015-0016-z |
Ejemplares similares
-
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function
por: Heine, Annkristin, et al.
Publicado: (2015) -
Spoilt for choice: different immunosuppressive potential of anaplastic lymphoma kinase inhibitors for non small cell lung cancer
por: Heine, Annkristin, et al.
Publicado: (2023) -
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways
por: Kotthoff, Philipp, et al.
Publicado: (2017) -
RNA Vaccines in Cancer Treatment
por: Bringmann, Anita, et al.
Publicado: (2010) -
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells
por: Braun, Christiane, et al.
Publicado: (2021)